Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in alzheimer's presenile dementia

C. Caltagirone, G. Gainotti, C. Masullo

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Physostigmine was administered orally 1 mg q.i.d. for one month to 8 patients with a clinical diagnosis of Alzheimer's presenile dementia. The possible beneficial effects of the drug were evaluated by means of a neuropsychological battery administered to all patients before and after treatment. The performances obtained by demented patients on vetest did not show any difference in comparison with performances obtained on the first neuropsychologic assessment. Some implications of these negative results are briefly discussed.

Original languageEnglish
Pages (from-to)247-249
Number of pages3
JournalInternational Journal of Neuroscience
Volume16
Issue number3-4
DOIs
Publication statusPublished - 1982

Fingerprint

Physostigmine
Oral Administration
Alzheimer Disease
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in alzheimer's presenile dementia. / Caltagirone, C.; Gainotti, G.; Masullo, C.

In: International Journal of Neuroscience, Vol. 16, No. 3-4, 1982, p. 247-249.

Research output: Contribution to journalArticle

@article{2440bd19b3e4469ca1015127c07ca791,
title = "Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in alzheimer's presenile dementia",
abstract = "Physostigmine was administered orally 1 mg q.i.d. for one month to 8 patients with a clinical diagnosis of Alzheimer's presenile dementia. The possible beneficial effects of the drug were evaluated by means of a neuropsychological battery administered to all patients before and after treatment. The performances obtained by demented patients on vetest did not show any difference in comparison with performances obtained on the first neuropsychologic assessment. Some implications of these negative results are briefly discussed.",
author = "C. Caltagirone and G. Gainotti and C. Masullo",
year = "1982",
doi = "10.3109/00207458209147153",
language = "English",
volume = "16",
pages = "247--249",
journal = "International Journal of Neuroscience",
issn = "0020-7454",
publisher = "Informa Healthcare",
number = "3-4",

}

TY - JOUR

T1 - Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in alzheimer's presenile dementia

AU - Caltagirone, C.

AU - Gainotti, G.

AU - Masullo, C.

PY - 1982

Y1 - 1982

N2 - Physostigmine was administered orally 1 mg q.i.d. for one month to 8 patients with a clinical diagnosis of Alzheimer's presenile dementia. The possible beneficial effects of the drug were evaluated by means of a neuropsychological battery administered to all patients before and after treatment. The performances obtained by demented patients on vetest did not show any difference in comparison with performances obtained on the first neuropsychologic assessment. Some implications of these negative results are briefly discussed.

AB - Physostigmine was administered orally 1 mg q.i.d. for one month to 8 patients with a clinical diagnosis of Alzheimer's presenile dementia. The possible beneficial effects of the drug were evaluated by means of a neuropsychological battery administered to all patients before and after treatment. The performances obtained by demented patients on vetest did not show any difference in comparison with performances obtained on the first neuropsychologic assessment. Some implications of these negative results are briefly discussed.

UR - http://www.scopus.com/inward/record.url?scp=0020032644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020032644&partnerID=8YFLogxK

U2 - 10.3109/00207458209147153

DO - 10.3109/00207458209147153

M3 - Article

C2 - 7169287

AN - SCOPUS:0020032644

VL - 16

SP - 247

EP - 249

JO - International Journal of Neuroscience

JF - International Journal of Neuroscience

SN - 0020-7454

IS - 3-4

ER -